Tailoring the use of central pancreatectomy

Tailoring the use of central pancreatectomy through prediction models for major morbidity and postoperative diabetes: international retrospective multicenter study

Which patients benefit from central pancreatectomy (CP) and should therefore selected?
Findings: The multicenter international study on 838 patients after CP from 51 centers in 19 countries reported major morbidity in 248 (30%) patients, POPF ISGPS grade B/C in 365 (44%), and in-hospital mortality in 11 (1%) and provides two risk models for postoperative major morbidity and endocrine dysfunction after CP.
Meaning: Central pancreatectomy may be considered in patients with symptomatic benign and low-grade lesions in the body and neck of the pancreas since it lowers the risk of endocrine and exocrine insufficiency. The use of CP can be tailored using the risk models for major morbidity and endocrine dysfunction.
Research authors: Eduard van Bodegraven
Version: 1.10
  • Details
  • Save input
  • Load input

Calculate the result

Set more parameters to perform the calculation
Calculation error. Please check the model..

Conditional information

{{ file.classification }}
Notes are only visible in the result download and will not be saved by Evidencio

This model is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying models Part of
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
Evidencio v3.26 © 2015 - 2024 Evidencio. All Rights Reserved